HOME >> BIOLOGY >> NEWS
March of Dimes statement on newborn screening report

WHITE PLAINS, N.Y., SEPT. 22, 2004 -- The March of Dimes today issued the following statement on the report on newborn screening prepared for the Maternal and Child Health Bureau of the U.S. Health Resources and Services Administration by the American College of Medical Genetics (ACMG):

The March of Dimes supports comprehensive newborn screening for all babies in this country, regardless of their place of birth. Our policy is to support screening for specific conditions when there is a documented benefit to the child and there is a reliable test that enables early detection from newborn blood spots or other means. We support parents' rights to be fully informed about their baby's screening results, and we support expansion of health care provider education about newborn screening. March of Dimes state chapters and their partners work closely with governors, state legislators, and health departments to improve state newborn screening programs.

The March of Dimes strongly commends the ACMG report for advancing the field of newborn screening, defining a uniform panel for newborn screening, and providing a policy framework for the states. We support the recommendations in this report and we urge the Secretary of Health and Human Services to accept them as a national standard for newborn screening.

Based on the findings of this report, the March of Dimes will expand our policy on newborn screening as follows:

We will urge every state to screen every baby for at least the 30 disorders listed in the ACMG report. These 30 disorders meet our inclusion criteria, and include all of the nine metabolic tests plus hearing screening contained in our previous policy. We will revise our periodic evaluation of states' performance on newborn screening to include at least these 30.

We will urge states to provide test results for an additional 25 "reportable" conditions named in the ACMG report for which there are reliable t
'"/>

Contact: Michele Kling
mkling@marchofdimes.com
914-997-4613
March of Dimes Birth Defects Foundation
22-Sep-2004


Page: 1 2

Related biology news :

1. Folic acid vitamin use by women reaches all-time high, March of Dimes survey finds
2. Only 21 states offer newborn screening tests recommended by March of Dimes
3. March of Dimes awards $250,000 prize to pioneering scientist
4. Nanotechnology highlights from the ACS national meeting in Anaheim, Calif., March 28-April 1
5. Media advisory: Sea of Cortez expedition to launch March 26
6. Other highlights of the March 17 issue of JNCI
7. JCI table of contents, 15 March 2004
8. USGS March science picks
9. Other highlights in the March 3 issue of JNCI
10. JCI table of contents, March 1 2004
11. 2nd Annual CDB Symposium: Developmental Remodeling (March 29 - 31, 2004; Kobe, Japan)

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
Breaking Biology News(10 mins):
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
(Date:10/9/2017)... Phoenix, Arizona (PRWEB) , ... October 09, 2017 ... ... of Kindred, a four-tiered line of medical marijuana products targeting the needs of ... production and packaging of Kindred takes place in Phoenix, Arizona. , As operators ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially available Hi-C ... software to perform Hi-C metagenome deconvolution using their own facilities, supplementing the ...
(Date:10/6/2017)... ... October 06, 2017 , ... ... discussion and webinar on INSIGhT, the first-ever adaptive clinical trial for glioblastoma (GBM). ... Institute. The event is free and open to the public, but registration is ...
Breaking Biology Technology:
Cached News: